CLASS II Drug recall · Reported 14 Aug 2019 · FDA Enforcement Report
Midazolam 1MG/ML IN Nacl 9% Inj Sol Syr (C-iv) per syringe recalled
RXQ Compounding is recalling Midazolam 1MG/ML IN Nacl 9% Inj Sol Syr (C-iv) per syringe, Rxq Compounding, 340 West, distributed nationwide in the US. The recall was initiated on 19 Jun 2019 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1682-2019
- FDA event ID
- 83074
- Recalling firm
- RXQ Compounding, Athens, OH
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 19 Jun 2019
- FDA classified
- 8 Aug 2019
- Reported
- 14 Aug 2019
- Type
- Voluntary: Firm initiated
- Customers notified by
- Press Release
- Reason category
- Sterility
- Drug class
- Compounded Drugs
Timeline
| 19 Jun 2019 | Recall initiated by company | |
| 8 Aug 2019 | Classified by FDA | +50 days |
| 14 Aug 2019 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of Assurance of Sterility
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
MIDAZOLAM 1MG/ML IN NACL 0.9% INJ SOL SYR (C-IV), 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0135-86
Where it was distributed
Nationwide USA
Questions about this recall
Is Midazolam 1MG/ML IN Nacl 9% Inj Sol Syr (C-iv) per syringe, Rxq Compounding, 340 West recalled?
Yes. RXQ Compounding recalled Midazolam 1MG/ML IN Nacl 9% Inj Sol Syr (C-iv) per syringe, Rxq Compounding, 340 West on 19 Jun 2019. The recall is Class II and its status is Terminated. Recall number D-1682-2019.
Why was it recalled?
Lack of Assurance of Sterility
Which lots are affected?
All lots within expiry
Where was it sold?
Nationwide USA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from RXQ Compounding
All 88| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Edetate Calcium Disodium 150MG/ML Injectable per vial recalled | RXQ Compounding | Sterility | Nationwide |
| Drug | CLASS II | Neostigmine Methyl Sulfate 1MG/ML Inj Sol Syr per syringe recalled | RXQ Compounding | Sterility | Nationwide |
| Drug | CLASS II | Ondansetron 2 MG/ML Injection Solution (Npf) per vial recalled | RXQ Compounding | Sterility | Nationwide |
| Drug | CLASS II | Glutathione 200MG/ML (Pfv) Injection Soln per vial recalled | RXQ Compounding | Sterility | Nationwide |
| Drug | CLASS II | Phenylephrine HCL 100 Mcg/ML IN Nacl 9% Syr per syringe recalled | RXQ Compounding | Sterility | Nationwide |